Neuphoria Therapeutics (NEUP) Payables (2020 - 2026)
Neuphoria Therapeutics (NEUP) recorded Payables of $385,584 in fiscal Q4 2026 (quarter ended Jun 30, 2026), down 66.6% from $1.15 million a year earlier and down 38.5% from the prior quarter.
Powered by 
Analysis
Neuphoria Therapeutics (NEUP) Payables (2020 - 2026) Analysis & Trends
Starting with fiscal Q4 2020, Neuphoria Therapeutics' Payables history includes 13 quarters.
- Annual Payables has declined for three straight fiscal years, with a five-year compound annual growth rate of -22.7% (FY2021 to FY2026).
- Across earlier fiscal years, Payables came in at $1.15 million in FY2025 (-48.5%), $2.24 million in FY2024 (-4.1%), $2.34 million in FY2023 (+17.2%) and $2 million in FY2022 (+42.8%).
- The fiscal Q4 2026 figure is the lowest quarterly Payables in data going back to fiscal Q4 2020.
- On a year-over-year basis, Payables has declined for three consecutive quarters, with an average decline of 38.7% over the last five quarters.
- Peak year-over-year performance for Payables in the last five years was growth of 42.8% in fiscal Q4 2022, against a decline of 66.6% in fiscal Q4 2026 at the low end.
- Per Business Quant, the preceding three fiscal quarters came in at $627,185 (Q3 2026), $520,709 (Q2 2026) and $1.37 million (Q1 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 20.92 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 33.30 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 5.96 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 4.26 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -22.89 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 2.87 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 674.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 7.03 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 429.50 Mn |
| 10 | Neuphoria Therapeutics | 443.79 Mn | 368.60 Mn | - | 385,584.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 385,584.00 |
| Mar 31, 2026 | 627,185.00 |
| Dec 31, 2025 | 520,709.00 |
| Sep 30, 2025 | 1.37 Mn |
| Jun 30, 2025 | 1.15 Mn |
| Mar 31, 2025 | 745,336.00 |
| Dec 31, 2024 | 1.53 Mn |
| Sep 30, 2024 | 1.33 Mn |
| Jun 30, 2024 | 2.24 Mn |
| Jun 30, 2023 | 2.34 Mn |
| Jun 30, 2022 | 2.00 Mn |
| Jun 30, 2021 | 1.40 Mn |
| Jun 30, 2020 | 1.52 Mn |
API Access
Neuphoria Therapeutics Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=payables&ticker=NEUP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "payables", "ticker": "NEUP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=payables&ticker=NEUP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();